Safety of Cultured Allogeneic Adult Umbilical Cord or Placental Derived Mesenchymal Stem Cells for OA
- NCT ID
- NCT05147675
- Registry status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 1
- Sponsor
- The Foundation for Orthopaedics and Regenerative Medicine
- Conditions
- Osteoarthritis, Spinal Arthritis
Overview
ClinicalTrials.gov lists this study as Recruiting.
Official title: Safety of Cultured Allogeneic Adult Umbilical Cord or Placental Derived Mesenchymal Stem Cells for the Treatment of Osteoarthritis
Enrollment: 92 participants (Estimated).
What is being studied
- Biological: AlloRx
Who may be eligible
- Ages
- Not specified in the registry data
- Sex
- All
- Healthy volunteers accepted
- No
ClinicalTrials.gov lists the following eligibility criteria.
Study locations
2 study locations are listed.
Recruiting site status is explicitly provided for 2 locations; 2 are listed as Recruiting.
Countries: Greece, United States
- Florida, United States: 1
Sample of listed locations
- Prodromos Stem Cell Institute — Athens, Greece — Recruiting
- Prodromos Stem Cell Institute — Naples, Florida, 34102, United States — Recruiting
Study details
- Start date
- December 1, 2022
- Primary completion date
- December 1, 2027
- Completion date
- December 1, 2027
- First posted
- December 7, 2021
Source and update information
- Source
- ClinicalTrials.gov
- NCT ID
- NCT05147675
- Registry last updated
- October 16, 2026
- QualifiedStudies registry data refreshed
- October 19, 2026
- QualifiedStudies record fetched
- October 19, 2026
View NCT05147675 on ClinicalTrials.gov
Trial information can change. Confirm current study details with the study team or the registry.
About joining clinical research
Find clinical trials you may match with
QualifiedStudies can help you search for research opportunities related to your health. Availability of this specific study through QualifiedStudies has not been established.
Find clinical trials you may match with | Clinical trial FAQ